TrialAnnals of hematology2020

The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of Pet-guided treatments.

Alessia Bari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.